Global Pneumococcal Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Pneumococcal Vaccination market size was valued at US$ 9901 million in 2024 and is forecast to a readjusted size of USD 19620 million by 2031 with a CAGR of 10.4% during review period.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.

This report is a detailed and comprehensive analysis for global Pneumococcal Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Pneumococcal Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Pneumococcal Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Pneumococcal Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Pneumococcal Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pneumococcal Vaccination

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pneumococcal Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GSK, MSD, CDIBP, WALVAX, Sinovac, Bio Kangtai, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Pneumococcal Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
PPSV 23
PCV 13
PCV 10

Market segment by Application
Child
Adult

Major players covered
Pfizer
GSK
MSD
CDIBP
WALVAX
Sinovac
Bio Kangtai

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pneumococcal Vaccination product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pneumococcal Vaccination, with price, sales quantity, revenue, and global market share of Pneumococcal Vaccination from 2020 to 2025.

Chapter 3, the Pneumococcal Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pneumococcal Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pneumococcal Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccination.

Chapter 14 and 15, to describe Pneumococcal Vaccination sales channel, distributors, customers, research findings and conclusion.